China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

The National Institutes of Health has renewed funding for the Antibacterial Resistance Leadership Group (ARLG) with up to $102.5 million over seven years.

After years developing technology to do multiplex testing for infectious diseases, Enigma Diagnostics shuttered about two years ago without much fanfare. But thanks to a former investor in the company, Enigma's technology may live on.

Computational technology company Nvidia has acquired sequencing analysis software developer Parabricks. Terms were not disclosed.

Promega said on Thursday that it has signed a license agreement for MilliporeSigma's foundational CRISPR genome editing technology.

Curetis said after the close of the market on Friday that the US Food and Drug Administration has cleared the company's Unyvero LRT lower respiratory tract application cartridge for marketing in the US.

Molecular diagnostics firm ChromaCode said on Tuesday that it has raised $28 million in Series C financing.

Bio-Rad Laboratories disclosed in a Form 8-K filed with the US Securities and Exchange Commission on Friday that it was the victim of a ransomware attack on its network the day before.

Roche Licenses Codexis DNA Ligase Enzyme for NGS Library Prep Kits

Roche announced Monday the launch of its Cobas Zika test in countries that accept the CE mark.

Qiagen announced earlier this week that it has completed a strategic review, and after receiving interest from unnamed parties, the firm has decided to remain a stand-alone business.